Age and vitamin D affect the magnitude of the antibody response to the first dose of the SARS-CoV-2 BNT162b2 vaccine

BACKGROUND: Most approved vaccines utilise a two-dose strategy. To enable larger groups of patients to receive the first dose, the UK government increased the gap between the two doses from three to twelve weeks. Here we report on the immunogenicity of the first dose, including effect of age and vit...

Descripción completa

Detalles Bibliográficos
Autores principales: Piec, Isabelle, Cook, Laura, Dervisevic, Samir, Fraser, William D, Ruetten, Scott, Berman, Marvin, English, Emma, John, W Garry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Masson SAS. 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8923881/
https://www.ncbi.nlm.nih.gov/pubmed/35390564
http://dx.doi.org/10.1016/j.retram.2022.103344

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8923881/
https://www.ncbi.nlm.nih.gov/pubmed/35390564
http://dx.doi.org/10.1016/j.retram.2022.103344

Ejemplares similares